Table 5.

Genotype frequencies of polymorphisms of EGF gene in kidney transplant patients with and without acute rejection episodes.

SNP	Genotype	Non-AR	AR	Models	OR (95% CI)	p Value
		n (%)	n (%)
rs11568835	G/G	175 (61.6%)	47 (74.6%)	Codominant1	0.64 (0.34–1.20)	.16
	A/G	93 (32.8%)	16 (25.4%)	Codominant2	0.00 (0.00–NA)	.047
	A/A	16 (5.6%)	0 (0%)	Dominant	0.52 (0.28–0.97)	.034
				Recessive	0.00 (0.00–NA)	.0076
				Log-additive	0.50 (0.28–0.88)	.0099
rs11568943	G/G	181 (63.7%)	39 (61.9%)	Codominant1	1.02 (0.56–1.85)	.95
	A/G	91 (32%)	20 (31.8%)	Codominant2	1.55 (0.47–5.05)	.47
	A/A	12 (4.2%)	4 (6.3%)	Dominant	1.10 (0.62–1.94)	.75
				Recessive	1.53 (0.47–4.95)	.5
				Log-additive	1.13 (0.71–1.80)	.6
rs2237051	A/A	140 (49.3%)	29 (46%)	Codominant1	1.11 (0.63–1.99)	.72
	A/G	117 (41.2%)	27 (42.9%)	Codominant2	1.25 (0.50–3.15)	.63
	G/G	27 (9.5%)	7 (11.1%)	Dominant	1.08 (0.62–1.87)	.8
				Recessive	1.20 (0.49–2.93)	.69
				Log-additive	1.08 (0.72–1.64)	.7
rs11569017	A/A	178 (62.7%)	38 (60.3%)	Codominant1	1.03 (0.57–1.85)	.94
	T/A	96 (33.8%)	21 (33.3%)	Codominant2	1.87 (0.56–6.30)	.31
	T/T	10 (3.5%)	4 (6.3%)	Dominant	1.15 (0.65–2.02)	.63
				Recessive	2.02 (0.60–6.78)	.28
				Log-additive	1.21 (0.76–1.95)	.43
rs3756261	A/A	180 (63.6%)	37 (58.7%)	Codominant1	1.19 (0.66–2.14)	.56
	A/G	90 (31.8%)	22 (34.9%)	Codominant2	1.50 (0.46–4.85)	.50
	G/G	13 (4.6%)	4 (6.3%)	Dominant	1.26 (0.72–2.22)	.42
				Recessive	1.43 (0.45–4.60)	.56
				Log-additive	1.23 (0.78–1.94)	.37

EGF: epidermal growth factor; AR: acute rejection.